Literature DB >> 34075487

Clinical and surgical factors affecting the prognosis and survival rates in patients with mucormycosis.

Harun Gür1, Onur İsmi2, Yusuf Vayısoğlu2, Kemal Görür2, Rabia Bozdoğan Arpacı3, Elif Şahin Horasan4, Cengiz Özcan2.   

Abstract

PURPOSE: To investigate the factors affecting disease specific mortality (DSM) in patients with mucormycosis.
METHODS: This retrospective study included 24 patients diagnosed with mucormycosis and who had undergone surgical and medical treatment between 2010 and 2020. There were 14 male and 10 female patients whose mean age was 53.70 ± 16.87 years, range 18-83. We reviewed the factors affecting DSM, including the extent of disease (paranasal sinus, palatal, orbital or intracranial involvement) and blood parameters (BP) that are serum glucose level (SGL), white blood cell, neutrophil, lymphocyte counts, C-reactive protein and hemoglobulin levels. Also, the effect of SGL in diabetes mellitus and BP in hematological malignancies on DSM was additionally evaluated.
RESULTS: Orbital (p = 0.001) and intracranial (p < 0.01) involvement had statistically significant effect on DSM but not the palatal involvement. When Cox regression analysis was employed to analyze the effect of multiple independent factors on DSM, only the extent of disease (p = 0.023) had statistically significant effect. Receiver operating characteristic analysis of SGL for diabetic patients demonstrated that the area under the curve was 0.917 (p = 0.016). A cut-off SGL of 360 mg/dl revealed an 83.3% sensitivity and 83.3% specificity for mortality outcome for diabetic patients having mucormycosis.
CONCLUSION: Orbital or cerebral involvement is related to a poor prognosis, so early endoscopic nasal examination, diagnosis and treatment are of vital importance for DSM in mucormycosis. Serum glucose level over 360 mg/dl in uncontrolled diabetic patients with fever, ophthalmological findings and facial hypoesthesia should necessitate a consultation to an otolaryngologist and an endoscopic careful nasal examination.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Diabetes mellitus; Hematologic malignancy; Invasive fungal rhinosinusitis; Mortality; Mucormycosis; Prognosis

Mesh:

Substances:

Year:  2021        PMID: 34075487     DOI: 10.1007/s00405-021-06910-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  16 in total

1.  Acute invasive fungal rhinosinusitis: evaluation of 26 patients treated with endonasal or open surgical procedures.

Authors:  Fikret Kasapoglu; Hakan Coskun; Omer Afsin Ozmen; Halis Akalin; Beyza Ener
Journal:  Otolaryngol Head Neck Surg       Date:  2010-11       Impact factor: 3.497

2.  Acute invasive fungal rhinosinusitis: our experience with 19 patients.

Authors:  Ahmet Emre Süslü; Oğuz Oğretmenoğlu; Nilda Süslü; Omer TaşkIn Yücel; Tevfik Metin Onerci
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-05-10       Impact factor: 2.503

3.  Acute invasive fungal rhinosinusitis: our 2 year experience and outcome analysis.

Authors:  Raghunath Shanbag; Nita Rachel Rajan; Arun Kumar
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-01-22       Impact factor: 2.503

Review 4.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Authors:  Maureen M Roden; Theoklis E Zaoutis; Wendy L Buchanan; Tena A Knudsen; Tatyana A Sarkisova; Robert L Schaufele; Michael Sein; Tin Sein; Christine C Chiou; Jaclyn H Chu; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2005-07-29       Impact factor: 9.079

Review 5.  Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.

Authors:  Oliver A Cornely; Ana Alastruey-Izquierdo; Dorothee Arenz; Sharon C A Chen; Eric Dannaoui; Bruno Hochhegger; Martin Hoenigl; Henrik E Jensen; Katrien Lagrou; Russell E Lewis; Sibylle C Mellinghoff; Mervyn Mer; Zoi D Pana; Danila Seidel; Donald C Sheppard; Roger Wahba; Murat Akova; Alexandre Alanio; Abdullah M S Al-Hatmi; Sevtap Arikan-Akdagli; Hamid Badali; Ronen Ben-Ami; Alexandro Bonifaz; Stéphane Bretagne; Elio Castagnola; Methee Chayakulkeeree; Arnaldo L Colombo; Dora E Corzo-León; Lubos Drgona; Andreas H Groll; Jesus Guinea; Claus-Peter Heussel; Ashraf S Ibrahim; Souha S Kanj; Nikolay Klimko; Michaela Lackner; Frederic Lamoth; Fanny Lanternier; Cornelia Lass-Floerl; Dong-Gun Lee; Thomas Lehrnbecher; Badre E Lmimouni; Mihai Mares; Georg Maschmeyer; Jacques F Meis; Joseph Meletiadis; C Orla Morrissey; Marcio Nucci; Rita Oladele; Livio Pagano; Alessandro Pasqualotto; Atul Patel; Zdenek Racil; Malcolm Richardson; Emmanuel Roilides; Markus Ruhnke; Seyedmojtaba Seyedmousavi; Neeraj Sidharthan; Nina Singh; János Sinko; Anna Skiada; Monica Slavin; Rajeev Soman; Brad Spellberg; William Steinbach; Ban Hock Tan; Andrew J Ullmann; Jörg J Vehreschild; Maria J G T Vehreschild; Thomas J Walsh; P Lewis White; Nathan P Wiederhold; Theoklis Zaoutis; Arunaloke Chakrabarti
Journal:  Lancet Infect Dis       Date:  2019-11-05       Impact factor: 25.071

6.  Role of middle turbinate biopsy in the diagnosis of fulminant invasive fungal rhinosinusitis.

Authors:  M B Gillespie; D M Huchton; B W O'Malley
Journal:  Laryngoscope       Date:  2000-11       Impact factor: 3.325

7.  Rhinocerebral mucormycosis: pathways of spread.

Authors:  Seid Mousa Sadr Hosseini; Peyman Borghei
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-05-13       Impact factor: 2.503

8.  Computed tomographic findings in patients with invasive fungal sinusitis.

Authors:  John M DelGaudio; Ron E Swain; Todd T Kingdom; Susan Muller; Patricia A Hudgins
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-02

9.  Rhino-orbito-cerebral mucormycosis in patients with diabetic ketoacidosis.

Authors:  Ramazan Gen; Elif Şahin Horasan; Yusuf Vaysoğlu; Rabia Bozdoğan Arpaci; Gülden Ersöz; Cengiz Özcan
Journal:  J Craniofac Surg       Date:  2013-03       Impact factor: 1.046

10.  Acute invasive fungal rhinosinusitis: Survival analysis and the prognostic indicators.

Authors:  Sercan Gode; Goksel Turhal; Kerem Ozturk; Abdulhalim Aysel; Rasit Midilli; Bulent Karci
Journal:  Am J Rhinol Allergy       Date:  2015 Nov-Dec       Impact factor: 2.467

View more
  1 in total

1.  Successful treatment of rhino-cerebral mucormycosis with dual antifungal therapy and minimal surgical debridement.

Authors:  Lauren Bougioukas; Cindy D Noyes; Katherine Peterson; Lindsay M Smith; Andrew J Hale
Journal:  IDCases       Date:  2022-09-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.